首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Testing the infection prevalence of schistosoma mansoni after mass drug administration by comparing sensitivity and specificity of species-specific repeat fragment amplification by PCR and loop-mediated isothermal amplification
【24h】

Testing the infection prevalence of schistosoma mansoni after mass drug administration by comparing sensitivity and specificity of species-specific repeat fragment amplification by PCR and loop-mediated isothermal amplification

机译:通过比较PCR和环介导的等温扩增的物种特异性重复片段扩增的敏感性和特异性血吸虫麦森治疗大规模药物管理后的感染患病率

获取原文
获取原文并翻译 | 示例
           

摘要

Schistosomiasis is a blood parasitic disease caused by trematode parasites of the genus Schistosoma. Schistosoma mansoni is one of the main contributors of the disease and90%of the global burden of schistosomiasis is in Africa. Mass drug administration (MDA) has been implemented to reduce the disease burden in endemic areas. Because of MDA, the diagnostic sensitivity and specificity for classical diagnostic tests are reduced. In any disease situation, diagnosis is vital in determining asymptomatic, concurrent, current, new, and reinfection cases to evaluate the efficacy of any control program. We have evaluated the positive infection for S. mansoni from filtered urine samples collected from Zambian school children after MDA using loop-mediated isothermal amplification (LAMP) and compared its sensitivity and specificity with polymerase chain reaction (PCR). One hundred eleven urine samples collected from school children aged between 7 and 15 years from Siavonga district in southern Zambia were evaluated by PCR and LAMP for DNA extracted by two different protocols (filter-based versus crude extraction). The infection prevalence was 77% with PCR and almost94%with mansoni-LAMP. Also,LAMPdetected16%(Qiagen extraction) and10%(LAMP-Procedure for Ultra Rapid Extraction) more positive S. mansoni infection than PCR. We have demonstrated the efficacy of LAMP in a laboratory setup after MDA. The possible inclusion of LAMP as a field-based point-of-care test for surveillance can provide reliable prevalence of schistosomiasis after MDA and help in determining the efficacy of a control program. ? 2019 by The American Society of Tropical Medicine and Hygiene.
机译:血吸虫病是由血吸虫属的Trematode寄生虫引起的血液寄生疾病。 Schistosoma Mansoni是该疾病的主要贡献者之一,血吸虫病全球负担的90%是非洲。已经实施了大规模药物管理局(MDA)以减少流行区域的疾病负担。由于MDA,诊断敏感性和古典诊断测试的特异性降低。在任何疾病情况下,诊断对于确定无症状,并发,电流,新的和重新感染案件至关重要,以评估任何控制计划的功效。通过使用环介导的等温扩增(灯)在MDA后,从赞比亚儿童收集的过滤尿液样本中评估了S. Mansoni的阳性感染。与聚合酶链反应(PCR)进行了其敏感性和特异性。通过PCR和灯从Siavonga区从7到15年间从学龄儿童收集的一百11个尿样由两种不同方案提取的DNA(基于滤光器与粗萃取)评估。 PCR,PCR和Mansoni-Lamp的感染患病率为77%。此外,LavelDetted16%(QIAGEN提取)和10%(超快速提取的灯泡程序)比PCR更多阳性S. mansoni感染。我们已经证明了MDA后灯在实验室设置中的疗效。作为监测的可能包含灯的可能包含灯可以在MDA之后提供可靠的血吸虫病患病率,并有助于确定控制程序的功效。还2019年由美国热带医学和卫生学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号